Lumateperone

Category: Antipsychotic



Lumateperone Overview

Lumateperone (INN; brand name Caplyta kp-LY-t, developmental codes ITI-007 and ITI-722) is a butyrophenone atypical antipsychotic developed by Intra-Cellular Therapies, licensed from Bristol-Myers Squibb, for the treatment of schizophrenia,[2] and currently in development for bipolar depression and other neurological indications.[3] The most common side effects include sleepiness and dry mouth.[4] Contents 1 Medical uses 1.1 Schizophrenia 2...

Read more Lumateperone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lumateperone

Recent Lumateperone Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lumateperone
  • Capsule: 42mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Lumateperone or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 November 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA